Volume 17 – Number 3

Efficacy and Tolerability of Integrase Inhibitors in Antiretroviral-Naive Patients

Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice

HIV-1 Group O Origin, Evolution, Pathogenesis, and Treatment: Unraveling the Complexity of an Outlier 25 Years Later

Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction

State of the Art of Dual Therapy in 2015

The START Trial: Definitive Evidence to Treat All HIV-Positive Persons Regardless of CD4 Counts

Antiviral Therapy must be Offered to all Hepatitis C Patients, as Antiretrovirals to all HIV-Positive Individuals

Hepatitis B Reactivation During Successful HCV Therapy

HIV Protease Inhibitors Associated with Increased HCV Viral Load in Coinfected Patients

HIV Conference